Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.

dc.contributor.authorPérez de Isla, Leopoldo
dc.contributor.authorAlonso, Rodrigo
dc.contributor.authorGómez de Diego, José Juan
dc.contributor.authorMuñiz-Grijalvo, Ovidio
dc.contributor.authorDíaz-Díaz, José Luis
dc.contributor.authorZambón, Daniel
dc.contributor.authorMiramontes, José Pablo
dc.contributor.authorFuentes, Francisco
dc.contributor.authorde Andrés, Raimundo
dc.contributor.authorWerenitzky, José
dc.contributor.authorPadró, Teresa
dc.contributor.authorSaltijeral, Adriana
dc.contributor.authorMata, Pedro
dc.contributor.authorSAFEHEART investigators
dc.date.accessioned2025-01-07T13:38:06Z
dc.date.available2025-01-07T13:38:06Z
dc.date.issued2020-11-18
dc.description.abstractHeterozygous familial hypercholesterolemia (FH) is associated with premature atherosclerotic cardiovascular disease. Semi-automated plaque characterization (SAPC) by coronary computed tomographic angiography (CTA) provides information regarding coronary plaque burden and plaque characterization. Our aim was to quantify and characterize the coronary plaque burden of patients with FH using SAPC analysis and to identify which factors are related to plaque burden and plaque characteristics. A second aim was to analyse the prognostic implications of these parameters. Two hundred and fifty-nine asymptomatic individuals with molecularly determined FH were enrolled in this follow-up cohort study and underwent a coronary CTA analysed with SAPC. Mean follow-up time after coronary CTA was 3.9 ± 2 years. Mean age was 46.9 (10.7) years (130 women, 50.2%). Median plaque burden was 25.0% (19.0-29.0), non-calcified plaque burden 22.83% (17.94-26.88), calcified plaque-burden 1.12% (0.31-2.86) and CCS 8.9 (0-93). Five-year risk was independently related to plaque burden, non-calcified plaque burden, calcified plaque burden and coronary calcium score (B:3.75, 95%CI:2.92-4.58; p  Coronary atherosclerosis and its qualitative components may be quantified by means of SAPC in patients with FH. Plaque burden, calcified plaque burden and non-calcified plaque burden were independently related to the estimated cardiovascular risk. Plaque burden was also related to prognosis.
dc.identifier.doi10.1016/j.atherosclerosis.2020.11.012
dc.identifier.essn1879-1484
dc.identifier.pmid33261814
dc.identifier.unpaywallURLhttp://www.atherosclerosis-journal.com/article/S0021915020315215/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25713
dc.journal.titleAtherosclerosis
dc.journal.titleabbreviationAtherosclerosis
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.number52-58
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectCardiovascular events
dc.subjectCoronary CTA
dc.subjectCoronary artery disease
dc.subjectCoronary plaque burden
dc.subjectFamilial hypercholesterolaemia
dc.subjectPlaque characterization
dc.subjectPrognosis
dc.subject.meshComputed Tomography Angiography
dc.subject.meshCoronary Angiography
dc.subject.meshCoronary Artery Disease
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshHyperlipoproteinemia Type II
dc.subject.meshMiddle Aged
dc.subject.meshPlaque, Atherosclerotic
dc.subject.meshPrognosis
dc.subject.meshRisk Factors
dc.titleCoronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number317

Files